Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: AIDS. 2022 Apr 1;36(5):637–646. doi: 10.1097/QAD.0000000000003160

Table 3.

Association between glycemic status and physical function: results from multivariate linear mixed models

Grip Strength Gait speed
Variables Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Age, years -0.129 (−0.166, −0.093) <0.001 -0.003 (−0.003, −0.002) <0.001
Glycemic status
Normal Ref Ref
IFG −0.144 (−0.429, 0.140) 0.321 −0.004 (−0.012, 0.003) 0.230
Controlled DM −0.560 (−1.096, −0.024) 0.040 −0.018 (−0.032, −0.005) 0.007
Uncontrolled DM −0.937 (−1.684, −0.190) 0.014 −0.007 (−0.026, 0.011) 0.437
HIV infection 0.483 (−0.269, 1.235) 0.208 −0.002 (−0.016, 0.012) 0.773
BMI (class)
Underweight/normal ref ref
Overweight 0.720 (0.334, 1.105) <0.001 −0.008 (−0.017, 0.001) 0.085
Obese 0.944 (0.406, 1.483) 0.001 −0.026 (−0.038, −0.013) <0.001
Race
White ref ref
Black −0.975 (−2.003, 0.053) 0.063 −0.047 (−0.067, −0.028) <0.001
Other −2.935 (−4.484, −1.386) <0.001 −0.006 (−0.035, 0.023) 0.684
College education 0.243 (−0.347, 0.832) 0.419 0.024 (0.011, 0.036) <0.001
Center
Baltimore ref ref
Chicago 0.331 (−0.752, 1.414) 0.549 −0.053 (−0.073, −0.033) <0.001
Pittsburgh 0.925 (−0.081, 1.932) 0.072 −0.055 (−0.073, −0.036) <0.001
Los Angeles −0.932 (−1.968, 0.104) 0.078 −0.063 (−0.082, −0.044) <0.001
Cohort
1984 ref ref
1987 1.154 (−0.582, 2.890) 0.193 −0.005 (−0.037, 0.027) 0.775
2001 2.019 (0.916, 3.122) <0.001 0.017 (−0.003, 0.038) 0.101
2010 1.370 (−0.219, 2.958) 0.091 −0.010 (−0.041, 0.020) 0.505
Smoking status
Never ref ref
Former −0.768 (−1.578, 0.042) 0.063 −0.025 (−0.040, −0.010) 0.001
Current −1.050 (−1.930, −0.169) 0.019 −0.041 (−0.058, −0.024) <0.001
History of cocaine use 0.421 (−0.297, 1.139) 0.251 0.009 (−0.005, 0.024) 0.194
History of marijuana use 0.528 (−0.231, 1.286) 0.173 0.014 (−0.001, 0.030) 0.074
Alcohol use status
None ref ref
Low-moderate 0.121 (−0.318, 0.560) 0.589 0.012 (0.001, 0.022) 0.033
Moderate-binge 0.074 (−0.454, 0.602) 0.784 0.009 (−0.004, 0.022) 0.161
Liver disease −0.648 (−2.217, 0.921) 0.418 −0.028 (−0.062, 0.006) 0.104
Kidney disease −0.345 (−0.721, 0.034) 0.075 −0.012 (−0.022, −0.003) 0.010
Hypertension 0.177 (−0.134, 0.489) 0.265 −0.001 (−0.009, 0.007) 0.813
Arthritis −0.702 (−1.372, −0.032) 0.040 −0.003 (−0.020, 0.014) 0.745
Depression (CESD⩾16) −0.388 (−0.705, −0.072) 0.016 −0.020 (−0.027, −0.012) <0.001
Testosterone use 0.379 (−0.235, 0.994) 0.226 −0.005 (−0.019, 0.010) 0.520
Hepatitis B infection 0.782 (−1.573, 3.137) 0.515 −0.034 (−0.079, 0.010) 0.129
Hepatitis C infection −2.297 (−3.773, −0.820) 0.002 −0.028 (−0.057, 0.002) 0.063